Herantis Pharma (OHEL:HRTIS) Interest Expense : €-0.01 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Herantis Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Herantis Pharma's interest expense for the six months ended in Dec. 2024 was € -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Herantis Pharma's Operating Income for the six months ended in Dec. 2024 was € -2.27 Mil. Herantis Pharma's Interest Expense for the six months ended in Dec. 2024 was € -0.00 Mil. Herantis Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Herantis Pharma Interest Expense Historical Data

The historical data trend for Herantis Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Herantis Pharma Interest Expense Chart

Herantis Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-1.08

-14.53

-0.07

-0.02

Herantis Pharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial															1.23	-0.03	-0.52	-	-

Herantis Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.01 Mil.

Herantis Pharma (OHEL:HRTIS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Herantis Pharma's Interest Expense for the six months ended in Dec. 2024 was €-0.00 Mil. Its Operating Income for the six months ended in Dec. 2024 was €-2.27 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was €0.03 Mil.

Herantis Pharma's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Herantis Pharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Herantis Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Herantis Pharma PLC (OHEL:HRTIS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bertel Jungin Aukio 1, Espoo, FIN, 02600

Website

https://www.herantis.com

Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinson's disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.

Herantis Pharma Headlines

No Headlines